Fromm MF - Search Results

1

Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1).

Hitzl M, Schaeffeler E, Hocher B, Slowinski T, Halle H, Eichelbaum M, Kaufmann P, Fritz P, Fromm MF, Schwab M. Hitzl M, et al. Among authors: fromm mf. Pharmacogenetics. 2004 May;14(5):309-18. doi: 10.1097/00008571-200405000-00006. Pharmacogenetics. 2004. PMID: 15115917

2

An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.

Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M. Kroemer HK, et al. Among authors: fromm mf. Circulation. 1994 May;89(5):2396-400. doi: 10.1161/01.cir.89.5.2396. Circulation. 1994. PMID: 7910120 Clinical Trial.

3

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.

Fromm MF, Busse D, Kroemer HK, Eichelbaum M. Fromm MF, et al. Hepatology. 1996 Oct;24(4):796-801. doi: 10.1002/hep.510240407. Hepatology. 1996. PMID: 8855178

4

Stereoselectivity in drug metabolism and action: effects of enzyme inhibition and induction.

Kroemer HK, Fromm MF, Eichelbaum M. Kroemer HK, et al. Among authors: fromm mf. Ther Drug Monit. 1996 Aug;18(4):388-92. doi: 10.1097/00007691-199608000-00013. Ther Drug Monit. 1996. PMID: 8857556

5

Loss of analgesic effect of morphine due to coadministration of rifampin.

Fromm MF, Eckhardt K, Li S, Schänzle G, Hofmann U, Mikus G, Eichelbaum M. Fromm MF, et al. Pain. 1997 Aug;72(1-2):261-7. doi: 10.1016/s0304-3959(97)00044-4. Pain. 1997. PMID: 9272811 Clinical Trial.

6

Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.

Fromm MF, Dilger K, Busse D, Kroemer HK, Eichelbaum M, Klotz U. Fromm MF, et al. Br J Clin Pharmacol. 1998 Mar;45(3):247-55. doi: 10.1046/j.1365-2125.1998.00669.x. Br J Clin Pharmacol. 1998. PMID: 9517368 Free PMC article. Clinical Trial.

7

Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6.

Dilger K, Greiner B, Fromm MF, Hofmann U, Kroemer HK, Eichelbaum M. Dilger K, et al. Among authors: fromm mf. Pharmacogenetics. 1999 Oct;9(5):551-9. Pharmacogenetics. 1999. PMID: 10591535

8

P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

Fromm MF. Fromm MF. Int J Clin Pharmacol Ther. 2000 Feb;38(2):69-74. doi: 10.5414/cpp38069. Int J Clin Pharmacol Ther. 2000. PMID: 10706193 Review.

9

Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.

Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF. Pauli-Magnus C, et al. Among authors: fromm mf. J Pharmacol Exp Ther. 2000 May;293(2):376-82. J Pharmacol Exp Ther. 2000. PMID: 10773005

10

The effect of rifampin treatment on intestinal expression of human MRP transporters.

Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M, Siegmund W, Schrenk D. Fromm MF, et al. Am J Pathol. 2000 Nov;157(5):1575-80. doi: 10.1016/S0002-9440(10)64794-3. Am J Pathol. 2000. PMID: 11073816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters